Chalazion Clinical Trial
Official title:
Efficacy of Intense Pulsed Light in the Treatment of Recurrent Chalazia
The purpose of the present study was to investigate the efficacy of intense pulse light and meibomian glands expression in cases of recurrent chalazion after surgery.
Status | Recruiting |
Enrollment | 35 |
Est. completion date | November 1, 2021 |
Est. primary completion date | August 1, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 24 Years to 74 Years |
Eligibility | Inclusion Criteria: - All patients had chronic unilateral recurrent chalazia that failed to resolve after conservative treatment that included warm compresses and antibiotic and steroid ophthalmic ointments. Exclusion Criteria: - (1) any intraocular inflammation, ocular infection, allergy, ocular surgery, or ocular trauma in the past 6 months; (2) any eyelid diseases or structural abnormality; (3) any systematic diseases may lead to dry eye or MGD; (4) skin cancer or pigmented lesion in the treatment zone. |
Country | Name | City | State |
---|---|---|---|
China | Second Affiliated Hospital of Zhejiang University Hospital | Hangzhou |
Lead Sponsor | Collaborator |
---|---|
Second Affiliated Hospital, School of Medicine, Zhejiang University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recurrence rate of chalazia | The recurrence rate of the recurrent chalazia | an average of 1 year | |
Secondary | NITBUT | non-invasive tear film breakup time | an average of 1 year | |
Secondary | meibomian expressibility and quality | The expressibility and quality score of the meibum | an average of 1 year | |
Secondary | TMH | tear meniscus height | an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01202747 -
Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction
|
Phase 2/Phase 3 | |
Completed |
NCT02338648 -
Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion
|
Phase 2 | |
Completed |
NCT00420628 -
Pediatric Zylet Safety and Efficacy Study
|
Phase 4 | |
Withdrawn |
NCT01763437 -
Intralesional Tetracycline Injection in the Treatment of Chalazia
|
Phase 0 | |
Completed |
NCT03248440 -
Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion
|
Phase 3 | |
Completed |
NCT00832130 -
Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye
|
N/A | |
Completed |
NCT04342507 -
Probiotics for Treatment of Chalazion in Adults
|
N/A | |
Completed |
NCT04322500 -
Probiotics for Chalaziosis Treatment in Children
|
N/A | |
Recruiting |
NCT02025023 -
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
|
Phase 3 | |
Recruiting |
NCT05512572 -
Therapeutic Efficacy of Intense Pulsed Light in the Treatment of Chalazion
|
N/A |